These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin. Pelled D; Lloyd-Evans E; Riebeling C; Jeyakumar M; Platt FM; Futerman AH J Biol Chem; 2003 Aug; 278(32):29496-501. PubMed ID: 12756243 [TBL] [Abstract][Full Text] [Related]
13. N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. Ranes MK; El-Abbadi M; Manfredi MG; Mukherjee P; Platt FM; Seyfried TN Br J Cancer; 2001 Apr; 84(8):1107-14. PubMed ID: 11308262 [TBL] [Abstract][Full Text] [Related]
14. NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin. Jeyakumar M; Smith DA; Williams IM; Borja MC; Neville DC; Butters TD; Dwek RA; Platt FM Ann Neurol; 2004 Nov; 56(5):642-9. PubMed ID: 15505823 [TBL] [Abstract][Full Text] [Related]
15. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice. Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605 [TBL] [Abstract][Full Text] [Related]
16. Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Jeyakumar M; Butters TD; Cortina-Borja M; Hunnam V; Proia RL; Perry VH; Dwek RA; Platt FM Proc Natl Acad Sci U S A; 1999 May; 96(11):6388-93. PubMed ID: 10339597 [TBL] [Abstract][Full Text] [Related]
17. Intravenous administration of scAAV9-Hexb normalizes lifespan and prevents pathology in Sandhoff disease mice. Niemir N; Rouvière L; Besse A; Vanier MT; Dmytrus J; Marais T; Astord S; Puech JP; Panasyuk G; Cooper JD; Barkats M; Caillaud C Hum Mol Genet; 2018 Mar; 27(6):954-968. PubMed ID: 29325092 [TBL] [Abstract][Full Text] [Related]
18. Phospholipid synthesis is decreased in neuronal tissue in a mouse model of Sandhoff disease. Buccoliero R; Bodennec J; Van Echten-Deckert G; Sandhoff K; Futerman AH J Neurochem; 2004 Jul; 90(1):80-8. PubMed ID: 15198669 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease. Baek RC; Martin DR; Cox NR; Seyfried TN Lipids; 2009 Mar; 44(3):197-205. PubMed ID: 19034545 [TBL] [Abstract][Full Text] [Related]
20. beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration. Kyrkanides S; Miller JH; Brouxhon SM; Olschowka JA; Federoff HJ Brain Res Mol Brain Res; 2005 Feb; 133(2):286-98. PubMed ID: 15710246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]